Hospital Universitario Infanta Leonor — Clinical Trial Site

138 Registered trials

51 Currently recruiting

Organisation

Hospital Universitario Infanta Leonor

Location

Madrid, Spain

Identifier

ORG-100041540

Address

Avenida Gran Via Del Este 80, 28031, Spain

Departments

#9104: Hematología
10008 : Gastroenterologia
7001: Hematología
7005_Pneumology
7512 Rheumatology
Allergology
Allergy
Aparato Digestivo
Cirugía general
Departamento de dermatologia
Dermatologia
Dermatology
Dermatology department
Digestive
Digestivo
Farmacia
Gastroenterology
Haematology
hematologia
hematologia y hematoterapia
Hematology
Hematology and Hemotherapy
Hematology Dept
Hematology Unit
Infectious disease
Infectious Diseases
Intensive Care Unit
Intensive Medicine
Internal Medicine
Internal Medicine department-Infectious diseases
Internal medicine service
Medical Oncology
Medicina Interna
Mori
N/A
NA
Nefrology
Nephrology
Neumología
Neumology
Neurology
Oncology
Oncology Department
Oncology Service
Orthopedic Surgery and Traumatology Service (Knee Unit)
Pediatria
Pneumologist
Pneumology
Pneumology Department
Psychiatry
Psyquiatry
Pulmonology
Reumathology
Reumatología
Rheumatology
Rheumatology Department
Servicio de Dermatologia
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Medicina Interna
Servicio de Neumologia

Clinical trials at this site (138)

Search interface

COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE Recruiting

2023-505868-11-00 CHRONIC RENAL DISEASE 5 2025-01-17
Efecto de la inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas oligometastásico (número limitado de metástasis) después… Recruiting

2023-508741-40-00 Non-small cell lung cancer 10 2025-01-14
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A multicenter, phase 2 randomized, open label study to evaluate the efficacy and security of zanubrutinib in combination with obinutuzumab i… Recruiting

2023-504647-14-00 Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic 4 2024-09-02
A study to investigate efficacy, safety, and tolerability of mavorixafor in participants with congenital and acquired primary autoimmune and… Recruiting

2023-508482-32-00 Neutropenias 5 2024-07-22
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Recruiting

2024-518844-20-00 Treatment of Acute Gout Flare 10 2023-10-03
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoria… Recruiting

2022-500408-22-00 Plaque Psoriasis 5 2022-09-14
A study to Investigate the efficacy and safety of Depemokimab compared with placebo in Adults with Hypereosinophilic Syndrome (HES) Recruiting

2023-510346-25-00 Hypereosinophilic Syndrome (HES) 5 2022-09-01
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2022-08-30
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituxim… Recruiting

2024-510690-16-00 Relapsed/refractory follicular lymphoma 5 2022-01-31
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachmen… Ended

2025-520629-19-00 HIV Infections 3 2025-10-01
A dose finding study with an anti-TSLP antibody (GSK5784283) in adults aged 18 to 75 years of age with uncontrolled asthma. Ended

2024-518321-15-00 Asthma 4 2025-05-30
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Partic… Ended

2023-509588-25-00 Hepatitis B 4 2025-02-11
PH 3b, CAB + RPV in people with suboptimal response to oral ART (CROWN) Ended

2024-515070-28-00 HIV Infections 5 2024-12-23
A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab compared with treatment withdrawal in… Ended

2023-508096-36-00 atopic dermatitis 5 2024-10-30
A research study to evaluate the efficacy and safety of cenerimod in subjects suffering from systemic lupus erythematosus Ended

2024-515871-37-00 Moderate to severe systemic lupus erythematosus 5 2024-10-24
A study to determine if ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy (IgAN) Ended

2023-507851-31-00 Immunoglobulin A Nephropathy (IgAN) 5 2024-09-23